The invention is directed to new drug hapten analogues comprising: (A) an active ester group; (B) a drug hapten nucleus selected from a hydantoin nucleus or a barbiturate nucleus and (C) a linking chain linking the 3-position of the drug hapten nucleus to the active ester group.
该发明涉及新药半抗原类似物,包括:(A)活性酯基团;(B)从恒嗪核或
巴比妥核中选择的药物半抗原核;以及(C)连接链将药物半抗原核的3位连接到活性酯基团。